Barinthus Biotherapeutics (BRNS) Non-Current Assets (2020 - 2026)
Barinthus Biotherapeutics' Non-Current Assets came in at $18.62 million for Q2 2026, down 36.1% from $29.15 million a year earlier and down 4.4% from the prior quarter.
Powered by 
Analysis
Barinthus Biotherapeutics (BRNS) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Barinthus Biotherapeutics' Non-Current Assets was $20.38 million, down 41.1% from FY2024.
- Non-Current Assets carries a five-year compound annual growth rate of 49.1% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $34.59 million in FY2024 (-40.0%), $57.6 million in FY2023 (+0.8%), $57.16 million in FY2022 (+6.0%) and $53.95 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Non-Current Assets since Q3 2021.
- Year-over-year, Non-Current Assets has declined for ten consecutive quarters, with an average decline of 39.1% over the last eight quarters.
- The fastest year-over-year change in Non-Current Assets over five years came in Q3 2022 (growth of 436.8%), and the weakest in Q3 2025 (a decline of 58.5%).
- Business Quant data shows BRNS's Non-Current Assets at $19.48 million (Q1 2026), $20.38 million (Q4 2025) and $22.42 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Barinthus Biotherapeutics | 30.23 Mn | 30.29 Mn | - | 18.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.62 Mn |
| Mar 31, 2026 | 19.48 Mn |
| Dec 31, 2025 | 20.38 Mn |
| Sep 30, 2025 | 22.42 Mn |
| Jun 30, 2025 | 29.15 Mn |
| Mar 31, 2025 | 32.11 Mn |
| Dec 31, 2024 | 34.59 Mn |
| Sep 30, 2024 | 54.04 Mn |
| Jun 30, 2024 | 54.87 Mn |
| Mar 31, 2024 | 56.35 Mn |
| Dec 31, 2023 | 57.60 Mn |
| Sep 30, 2023 | 58.91 Mn |
| Jun 30, 2023 | 61.35 Mn |
| Mar 31, 2023 | 61.15 Mn |
| Dec 31, 2022 | 57.16 Mn |
| Sep 30, 2022 | 56.86 Mn |
| Jun 30, 2022 | 58.77 Mn |
| Mar 31, 2022 | 55.34 Mn |
| Dec 31, 2021 | 53.95 Mn |
| Sep 30, 2021 | 10.59 Mn |
API Access
Barinthus Biotherapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=BRNS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "BRNS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=BRNS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();